Blue Fin Group, an IntegriChain Company

Welcome Federal Compliance Solutions, an IntegriChain Company to our extended family. We are excited to join forces and serve the net revenue optimization and patient access needs for the Pharma industry.

We're excited to announce that Nordic Capital-backed IntegriChain has acquired Federal Compliance Solutions, an IntegriChain Company, assembling the industry's most comprehensive team of experts in government pricing and payer/provider contracting. This strategic move will bolster IntegriChain's capabilities in the dynamic regulatory landscape and deliver unparalleled value to pharmaceutical clients. Read the full press release here: https://lnkd.in/d2YRvSWe

We are so excited to welcome Federal Compliance Solutions LLC to our IntegriChain team. Read more: https://bit.ly/4eSQOIp

William Roth Roth weighs in on the state of the generics industry and the Medicare Drug Shortage Prevention and Mitigation Program proposed legislation in Pharmacy Practice News Read his hot take: https://bit.ly/4eRSulB

Branded pharmaceutical manufacturers from large to emerging are struggling to ensure patients can find pharmacies that are capable and willing of dispensing Gen Med non-specialty brands, which account for 8% of the prescriptions that flow out of the pharmacy. Home delivery and digital pharmacy have attempted to provide feasible solutions, but to date have been insufficient to address these mounting barriers to access. Join Daniel Landis and Katie Herrick as they discuss these challenges in Part 1 of our 3 part webinar series on Optimizing Physical Access and Affordability Challenges for Branded Rx Products - Meeting a $35 Patient Out-of-Pocket Target. Register today. https://bit.ly/3W5tzn1

We are thrilled to announce the promotion of Jeffrey Baab to Partner on IntegriChain's Advisory Services team. Jeff is a trusted advisor to so many Pharma companies, guiding them through the latest legislative requirements, walking them through pricing and contracting scenarios, and helping them optimize their net revenue and patient access. He is also a trusted leader on our broader Consulting team and a popular frequent speaker at industry events. Congratulations, Jeff, on your well-deserved promotion!

The early bird discount for our Access Insights Conference ends June 18th. No matter the type of therapy you are bringing to market, we'll provide the latest data-driven commercialization strategies, tactics, insights, and benchmarks from October 14 - 16 at the Mayflower Hotel. Don't miss out and register today: https://lnkd.in/eYB8irsw

These four articles are an expert-level course in #Pharma distribution, reimbursement, and ecosystem profitability. If you like this content and insight, join use at our Access Insights 2024 conference! Register now: https://lnkd.in/eYB8irsw

Could it happen in #pharma? No more prior authorizations? Farewell to step-edits? Return of control of pricing to the patient/consumer? Sounds lovely, doesn’t it? Read William Roth's latest article to learn more about changes in drug distribution, pricing, access, and patient affordability.

Don't miss William Roth's thought-provoking series, Who Moved My Prescription? Part 4 in the Pharmaceutical Commerce Magazine: https://lnkd.in/eJTeUdij Who Moved My Prescription? Part 3:  https://lnkd.in/eurdjurg Who Moved My Prescription? Part 2: https://lnkd.in/eMucaqTs Who Moved My Prescription? Part 1: https://lnkd.in/eZcdMgKn